182 related articles for article (PubMed ID: 25602744)
1. Effect of diabetes mellitus on giant cell arteritis.
Abel AS; Yashkin AP; Sloan FA; Lee MS
J Neuroophthalmol; 2015 Jun; 35(2):134-8. PubMed ID: 25602744
[TBL] [Abstract][Full Text] [Related]
2. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
3. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
[TBL] [Abstract][Full Text] [Related]
4. The association of gout with incident giant cell arteritis in older adults.
Singh JA; Cleveland JD
Joint Bone Spine; 2019 Mar; 86(2):219-224. PubMed ID: 29885976
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus in biopsy-positive giant cell arteritis.
Matthews JL; Gilbert DN; Farris BK; Siatkowski RM
J Neuroophthalmol; 2012 Sep; 32(3):202-6. PubMed ID: 22549560
[TBL] [Abstract][Full Text] [Related]
6. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
7. Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.
England BR; Mikuls TR; Xie F; Yang S; Chen L; Curtis JR
Arthritis Rheumatol; 2017 Dec; 69(12):2351-2358. PubMed ID: 28853238
[TBL] [Abstract][Full Text] [Related]
8. Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients.
Lee MS; Grossman D; Arnold AC; Sloan FA
Ophthalmology; 2011 May; 118(5):959-63. PubMed ID: 21439645
[TBL] [Abstract][Full Text] [Related]
9. Incidence of giant cell arteritis after bisphosphonate exposure: A retrospective cohort study.
Mahmood SB; Ji Y; Peng Y; Abou Zahr Z
Int J Rheum Dis; 2021 Jan; 24(1):63-68. PubMed ID: 33150665
[TBL] [Abstract][Full Text] [Related]
10. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
11. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
12. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
Robson JC; Kiran A; Maskell J; Hutchings A; Arden N; Dasgupta B; Hamilton W; Emin A; Culliford D; Luqmani RA
Ann Rheum Dis; 2015 Jan; 74(1):129-35. PubMed ID: 24095936
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features.
González-Gay MA; Blanco R; Sánchez-Andrade A; Vázquez-Caruncho M
J Rheumatol; 1997 Nov; 24(11):2166-70. PubMed ID: 9375879
[TBL] [Abstract][Full Text] [Related]
14. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis treatment patterns and rates of serious infections.
Tedeschi SK; Jin Y; Vine S; Lee H; Pethoe-Schramm A; Yau V; Kim SC
Clin Exp Rheumatol; 2022 May; 40(4):826-833. PubMed ID: 34905480
[TBL] [Abstract][Full Text] [Related]
16. Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast.
Gonzalez EB; Varner WT; Lisse JR; Daniels JC; Hokanson JA
Arch Intern Med; 1989 Jul; 149(7):1561-5. PubMed ID: 2742429
[TBL] [Abstract][Full Text] [Related]
17. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.
Tomasson G; Bjornsson J; Zhang Y; Gudnason V; Merkel PA
Scand J Rheumatol; 2019 May; 48(3):213-217. PubMed ID: 30460876
[TBL] [Abstract][Full Text] [Related]
20. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations.
Bas-Lando M; Breuer GS; Berkun Y; Mates M; Sonnenblick M; Nesher G
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S15-7. PubMed ID: 17428357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
